Ki67 and CD30 Predict Survival in Non-Transformed Mycosis Fungoides

被引：0
|
作者：
Edinger, J. T. [1 ]
Clark, B. Z. [1 ]
Pucevich, B. E. [1 ]
Geskin, L. J. [1 ]
Swerdlow, S. H. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1188
引用
收藏
页码：261A / 261A
页数：1
相关论文
共 50 条
  • [41] Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides
    Mitteldorf, Christina
    Robson, Alistair
    Tronnier, Michael
    Pfaltz, Monique C.
    Kempf, Werner
    DERMATOLOGY, 2015, 231 (02) : 164 - 170
  • [42] CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides
    Simo, Olivia C.
    Warren, Simon J.
    Mark, Lawrence
    Hoffmann, Kristin
    Alomari, Ahmed K.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (07) : 800 - 805
  • [43] Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer
    Grant, Laurel
    Banerji, Shantanu
    Murphy, Leigh
    Dawe, David E.
    Harlos, Craig
    Myal, Yvonne
    Nugent, Zoann
    Blanchard, Anne
    Penner, Carla R.
    Qing, Gefei
    Pitz, Marshall W.
    HORMONES & CANCER, 2018, 9 (04): : 288 - 294
  • [44] Treatment of mycosis fungoides with brentuximab vedotin: Assessing CD30 expression by immunohistochemistry and quantitative real-time polymerase chain reaction
    Hofer, Vivian
    Maurus, Katja
    Houben, Roland
    Schrama, David
    Roth, Sabine
    Goebeler, Matthias
    Geissinger, Eva
    Rosenwald, Andreas
    Wobser, Marion
    JOURNAL OF CUTANEOUS PATHOLOGY, 2022, 49 (03) : 314 - +
  • [45] Spatially Resolved Transcriptomes of CD30D-Transformed Mycosis Fungoides and Cutaneous Anaplastic Large-Cell Lymphoma
    Choi, Myoung Eun
    Lee, Mi Young
    Won, Chong Hyun
    Chang, Sung Eun
    Lee, Mi Woo
    Lee, Woo Jin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (02) : 331 - 340.e2
  • [46] Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer
    Laurel Grant
    Shantanu Banerji
    Leigh Murphy
    David E. Dawe
    Craig Harlos
    Yvonne Myal
    Zoann Nugent
    Anne Blanchard
    Carla R. Penner
    Gefei Qing
    Marshall W. Pitz
    Hormones and Cancer, 2018, 9 : 288 - 294
  • [47] Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer
    Wang, Lujia
    Feng, Chenchen
    Ding, Guanxiong
    Ding, Qiang
    Zhou, Zhongwen
    Jiang, Haowen
    Wu, Zhong
    TUMOR BIOLOGY, 2014, 35 (04) : 2989 - 2995
  • [48] Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sezary syndrome with variable CD30 positivity
    Papadavid, E.
    Kapniari, E.
    Pappa, V.
    Nikolaou, V.
    Iliakis, T.
    Dalamaga, M.
    Jonak, C.
    Porkert, S.
    Engelina, S.
    Quaglino, P.
    Ortiz-Romero, P. L.
    Vico, C.
    Cozzio, A.
    Dimitriou, F.
    Guiron, R.
    Guenova, E.
    Hodak, E.
    Bagot, M.
    Scarisbrick, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 1035 - 1044
  • [49] PRIMARY CUTANEOUS CD30(KI-1)-POSITIVE LYMPHOMA OF NON-T, NON-B ORIGIN
    AKIYAMA, C
    SHIBAGAKI, N
    YASAKA, N
    OHTAKE, N
    KUBOTA, Y
    TAKAYAMA, O
    KATOH, R
    SHIMADA, S
    FURUE, M
    TAMAKI, K
    DERMATOLOGY, 1995, 190 (03) : 238 - 241
  • [50] The Ki67/CD138 Ratio Independently Predicts Overall Survival in the Upfront Treatment of Newly Diagnosed Multiple Myeloma
    Mark, Tomer M.
    Forsberg, Peter
    Ouansafi, Ihsane
    Rossi, Adriana C.
    Pearse, Roger N.
    Pekle, Karen
    Perry, Arthur
    Coleman, Morton
    Jayabalan, David
    Niesvizky, Ruben
    Ely, Scott A.
    BLOOD, 2014, 124 (21)
12345